- cafead   Dec 05, 2023 at 10:22: AM
via Swiss pharmaceutical company Roche has reported positive data from the Phase III INAVO120 clinical trial of its investigational therapy, inavolisib, alongside palbociclib (Ibrance) and fulvestrant to treat locally advanced or metastatic breast cancer.
article source
article source